Volumetric Regression in Brain Metastases After Stereotactic Radiotherapy: Time Course, Predictors, and Significance

التفاصيل البيبلوغرافية
العنوان: Volumetric Regression in Brain Metastases After Stereotactic Radiotherapy: Time Course, Predictors, and Significance
المؤلفون: Thomas Weissmann, Dominik Oft, Rainer Fietkau, Johannes Roesch, Luitpold Distel, Sebastian Lettmaier, Florian Putz, Siti Masitho, Christoph Bert, Manuel Schmidt, Veit Mengling, Benjamin Frey
المصدر: Frontiers in Oncology, Vol 10 (2021)
Frontiers in Oncology
بيانات النشر: Frontiers Media S.A., 2021.
سنة النشر: 2021
مصطلحات موضوعية: Cancer Research, medicine.medical_specialty, Multivariate analysis, medicine.medical_treatment, stereotactic radiosurgery, lcsh:RC254-282, 030218 nuclear medicine & medical imaging, Metastasis, Stereotactic radiotherapy, 03 medical and health sciences, 0302 clinical medicine, Bayesian multivariate linear regression, brain metastases, Medicine, ddc:610, Original Research, business.industry, volumetric regression, longitudinal analysis, medicine.disease, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Regression, Clinical trial, Radiation therapy, Oncology, 030220 oncology & carcinogenesis, Time course, volumetric analysis, stereotactic radiotherapy, Radiology, business, MRI
الوصف: BackgroundThere is insufficient understanding of the natural course of volumetric regression in brain metastases after stereotactic radiotherapy (SRT) and optimal volumetric criteria for the assessment of response and progression in radiotherapy clinical trials for brain metastases are currently unknown.MethodsVolumetric analysis via whole-tumor segmentation in contrast-enhanced 1 mm³-isotropic T1-Mprage sequences before SRT and during follow-up. A total of 3,145 MRI studies of 419 brain metastases from 189 patients were segmented. Progression was defined using a volumetric extension of the RANO-BM criteria. A subset of 205 metastases without progression/radionecrosis during their entire follow-up of at least 3 months was used to study the natural course of volumetric regression after SRT. Predictors for volumetric regression were investigated. A second subset of 179 metastases was used to investigate the prognostic significance of volumetric response at 3 months (defined as ≥20% and ≥65% volume reduction, respectively) for subsequent local control.ResultsMedian relative metastasis volume post-SRT was 66.9% at 6 weeks, 38.6% at 3 months, 17.7% at 6 months, 2.7% at 12 months and 0.0% at 24 months. Radioresistant histology and FSRT vs. SRS were associated with reduced tumor regression for all time points. In multivariate linear regression, radiosensitive histology (p=0.006) was the only significant predictor for metastasis regression at 3 months. Volumetric regression ≥20% at 3 months post-SRT was the only significant prognostic factor for subsequent control in multivariate analysis (HR 0.63, p=0.023), whereas regression ≥65% was no significant predictor.ConclusionsVolumetric regression post-SRT does not occur at a constant rate but is most pronounced in the first 6 weeks to 3 months. Despite decreasing over time, volumetric regression continues beyond 6 months post-radiotherapy and may lead to complete resolution of controlled lesions by 24 months. Radioresistant histology is associated with slower regression. We found that a cutoff of ≥20% regression for the volumetric definition of response at 3 months post-SRT was predictive for subsequent control whereas the currently proposed definition of ≥65% was not. These results have implications for standardized volumetric criteria in future radiotherapy trials for brain metastases.
وصف الملف: application/pdf; image/tiff
اللغة: English
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::149ce0c5f432a16893a0ea6d00408771Test
https://www.frontiersin.org/articles/10.3389/fonc.2020.590980/fullTest
حقوق: OPEN
رقم الانضمام: edsair.doi.dedup.....149ce0c5f432a16893a0ea6d00408771
قاعدة البيانات: OpenAIRE